Search Page

1

Cite

Share

Comparison of sexual behavior and HIV risk between two HIV-1 serodiscordant couple cohorts: the CHAVI 002 study.

Ritchie AJ, Kuldanek K, Moodie Z, Wang ZM, Fox J, Nsubuga RN, Legg K, Birabwa EF, Kaleebu P, McMichael AJ, Watera C, Goonetilleke N, Fidler S. Ritchie AJ, et al. Among authors: legg k. PLoS One. 2012;7(5):e37727. doi: 10.1371/journal.pone.0037727. Epub 2012 May 22. PLoS One. 2012. PMID: 22629447 Free PMC article.

Cite

Share

2

Cite

Share

Differences in HIV-specific T cell responses between HIV-exposed and -unexposed HIV-seronegative individuals.

Ritchie AJ, Campion SL, Kopycinski J, Moodie Z, Wang ZM, Pandya K, Moore S, Liu MK, Brackenridge S, Kuldanek K, Legg K, Cohen MS, Delwart EL, Haynes BF, Fidler S, McMichael AJ, Goonetilleke N. Ritchie AJ, et al. Among authors: legg k. J Virol. 2011 Apr;85(7):3507-16. doi: 10.1128/JVI.02444-10. Epub 2011 Jan 26. J Virol. 2011. PMID: 21270166 Free PMC article.

Cite

Share

3

Cite

Share

Lessons from IAVI-006, a phase I clinical trial to evaluate the safety and immunogenicity of the pTHr.HIVA DNA and MVA.HIVA vaccines in a prime-boost strategy to induce HIV-1 specific T-cell responses in healthy volunteers.

Guimarães-Walker A, Mackie N, McCormack S, Hanke T, Schmidt C, Gilmour J, Barin B, McMichael A, Weber J, Legg K, Babiker A, Hayes P, Gotch F, Smith C, Dally L, Dorrell L, Cebere I, Kay R, Winstone N, Moore S, Goonetilleke N, Fast P; IAVI-006 Study Group. Guimarães-Walker A, et al. Among authors: legg k. Vaccine. 2008 Dec 2;26(51):6671-7. doi: 10.1016/j.vaccine.2008.09.016. Vaccine. 2008. PMID: 18812202 Clinical Trial.

Cite

Share

4

Cite

Share

EV02: a Phase I trial to compare the safety and immunogenicity of HIV DNA-C prime-NYVAC-C boost to NYVAC-C alone.

McCormack S, Stöhr W, Barber T, Bart PA, Harari A, Moog C, Ciuffreda D, Cellerai C, Cowen M, Gamboni R, Burnet S, Legg K, Brodnicki E, Wolf H, Wagner R, Heeney J, Frachette MJ, Tartaglia J, Babiker A, Pantaleo G, Weber J. McCormack S, et al. Among authors: legg k. Vaccine. 2008 Jun 13;26(25):3162-74. doi: 10.1016/j.vaccine.2008.02.072. Epub 2008 May 6. Vaccine. 2008. PMID: 18502003 Clinical Trial.

Cite

Share

5

Cite

Share

Participation in two phase II prophylactic HIV vaccine trials in the UK.

Gray K, Legg K, Sharp A, Mackie N, Olarinde F, De Souza C, Weber J, Peters B. Gray K, et al. Among authors: legg k. Vaccine. 2008 Jun 2;26(23):2919-24. doi: 10.1016/j.vaccine.2008.03.039. Epub 2008 Apr 9. Vaccine. 2008. PMID: 18450339

Cite

Share

6

Cite

Share

Developing a Bayesian adaptive design for a phase I clinical trial: a case study for a novel HIV treatment.

Mason AJ, Gonzalez-Maffe J, Quinn K, Doyle N, Legg K, Norsworthy P, Trevelion R, Winston A, Ashby D. Mason AJ, et al. Among authors: legg k. Stat Med. 2017 Feb 28;36(5):754-771. doi: 10.1002/sim.7169. Epub 2016 Nov 27. Stat Med. 2017. PMID: 27891651 Free PMC article.

Cite

Share

7

Cite

Share

Pharmacokinetic and safety profile of raltegravir and ribavirin, when dosed separately and together, in healthy volunteers.

Ashby J, Garvey L, Erlwein OW, Lamba H, Weston R, Legg K, Latch N, McClure MO, Dickinson L, D'Avolio A, Back D, Winston A. Ashby J, et al. Among authors: legg k. J Antimicrob Chemother. 2011 Jun;66(6):1340-5. doi: 10.1093/jac/dkr093. Epub 2011 Mar 15. J Antimicrob Chemother. 2011. PMID: 21406434 Clinical Trial.

Cite

Share

8

Cite

Share

Cerebrospinal fluid exposure of cenicriviroc in HIV-positive individuals with cognitive impairment.

Alagaratnam J, Dilly-Penchala S, Challenger E, Else L, Legg K, Petersen C, Jones B, Kulasegaram R, Seyedkazemi S, Lefebvre E, Khoo S, Winston A. Alagaratnam J, et al. Among authors: legg k. Br J Clin Pharmacol. 2019 May;85(5):1039-1040. doi: 10.1111/bcp.13878. Epub 2019 Mar 4. Br J Clin Pharmacol. 2019. PMID: 30834549 Free PMC article. No abstract available.

Cite

Share

9

Cite

Share

40^th EASD Annual Meeting of the European Association for the Study of Diabetes : Munich, Germany, 5-9 September 2004.

[No authors listed] [No authors listed] Diabetologia. 2004 Aug;47(Suppl 1):A1-A464. doi: 10.1007/BF03375463. Diabetologia. 2004. PMID: 27770180 Free PMC article. No abstract available.

Cite

Share

10

Cite

Share

Race-Level Reporting of Incidents during Two Seasons (2015/16 to 2016/17) of Thoroughbred Flat Racing in New Zealand.

Gibson MJ, Bolwell CF, Gee EK, Legg KA, Rogers CW. Gibson MJ, et al. Among authors: legg ka. Animals (Basel). 2022 Apr 15;12(8):1033. doi: 10.3390/ani12081033. Animals (Basel). 2022. PMID: 35454278 Free PMC article.

Cite

Share